HamburgAfter a bright period, HSV have slipped into worrying form. Their 1-0 defeat to Augsburg on November 22 typified ...

With much of Moderna’s recent rise tied to its COVID-19 vaccine, the company has struggled to match the sales highs it ...

FC Augsburg's hero of Saturday afternoon, Anton Kade, couldn't hide his happiness after his goal ensured a 1-0 victory over ...

In the 0:1 defeat against Augsburg, Daniel Heuer Fernandes was one of the few bright spots for HSV. Once again, he saved his ...

Today, Saturday, HSV will face FC Augsburg away. Despite Augsburg’s weak results so far, Merlin Polzin expects a strong ...

Researchers examined whether exposure to common infectious agents was associated with cognitive performance and risk for mild cognitive impairment or dementia in older adults.

Scenario: Third against fourth. Only one point separates the two teams. Leverkusen are in a Champions League spot for the first time this season and are also ahead of the Black & Yellows for the ...

A healthy 5-year-old boy came in from playing outside in the evening with the onset of pruritic skin lesions on the left ...

The IGNYTE trial reveals that RP1 combined with nivolumab offers significant, durable responses in advanced melanoma patients ...

SHELTON, CONNECTICUT / ACCESS Newswire / November 14, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the “Company”), a clinical stage leader developing revolutionary broad-spectrum antiviral drugs ...

Ruvidar and Rutherrin show strong potential in treating bladder cancer, solid tumors, and HSV-1—including drug-resistant strains—through light- and radiation-activated mechanisms that outperform ...

SHELTON, CONNECTICUT / ACCESS Newswire / November 10, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the “Company”) today ...